Question about in-vitro stimulation of T cells
Hello, I work extensively with ENCODE data (if you're not familiar with this, it's a big consortium that produces and analyzes various aspects of human and mouse genomes and genetic regulation, broadly speaking), and I am curious about how some of the T cell samples I work with were activated, since it doesn't exactly align with the canonical three-part activation I learned about in my undergraduate immunology class.
Basically, I am looking at differences in genome organization between resting and activated T cells, but the treatment protocols continue to confuse me. Here is the description from the lab that did the actual activation:
"CD4+ and CD8+ T cells and their subsets were left resting in culture or activated using anti-CD3 and anti-CD28 (aCD3/aCD28) coated beads (Invitrogen cat# 11132D) (1 bead:2 cells ratio) and cultured in complete RPMI 1640 at 10M/6ml/well in 6 well-plate. Resting cells and 90% of activated T cells were collected on day 2 (36 hours) and beads were removed using Dynal magnet. The rest of activated cells was expanded in rhIL-2 (10 ng/ml, R&D Systems cat# 10453-IL-100) containing media for 5 to 6 more days and collected on day 7 or day 8 post activation. Activation of T cells was confirmed by the upregulation of CD25 and CD69 surface expression analyzed by flow cytometry. For differentiation into different T helper (Th) subsets, Naïve CD4+ (sorted CD45RO- CCR7+) T cells were activated with anti-CD3 and anti-CD28 beads in the presence of the following polarizing cytokine and blocking antibody combinations: Th0, medium only, Th1, human IL-12 (R&D Systems cat# 219-IL-025; 30 ng/ml) and neutralizing anti-IL-4 Antibody (R&D Systems cat# AF-204-NA; 1 μg/ml), and Th2, human IL-4 (R&D Systems cat# 204-IL-020; 100 ng/ml) and neutralizing anti-IFN-γ Antibody (R&D Systems cat# MAB285-100; 5 μg/ml). Cells were cultured and expanded in rhIL-2 (10 ng/ml, R&D Systems cat# 10453-IL-100) containing media for 2 weeks. On day 13 after activation, some of the cells were reactivated with aCD3/aCD28 beads (at 1 bead:3 cells ratio) for another 24 hours."
Can anyone tell me if this is standard procedure for in vitro T cell stimulation that closely mimics in vivo activation, or is there something off here that I need to be aware of?
Thanks in advance for reading this and for your help!!